RSSCategory: Science

HalioDx receives CLIA Compliance for Immunoscore® Colon

| June 21, 2017 | 0 Comments

HalioDx receives CLIA Compliance for its laboratory based in Marseille Immunoscore® Colon, is now available to US patients in selected states with a turnaround time of 10 days Marseille, June 21, 2017 – HalioDx announced today that the company is compliant under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) for its Marseille-based full service […]

Continue Reading

PathPresenter.com – An Innovative Platform For Digital Pathology

| June 20, 2017 | 0 Comments

Let me describe a common scenario that plays out every week in a pathology department: You want to teach students, residents, or fellows a particular topic. You spend hours searching for cases and find some (but not enough) for a good teaching session. You know the department has a huge collection of great cases hiding […]

Continue Reading

Grail’s Billion Dollar Bet for the Perfect Cancer Test

| June 11, 2017 | 1 Comment

Thought this was worth sharing from MIT Technology Review. After attending ASCO last week what I thought might happen a year or two again actually has. Pathologists no longer have to worry about stepping out from behind the paraffin curtain as many of us were fond of saying. Tissue is not the issue anymore. At […]

Continue Reading

VisionGate Hires Dr. David Wilbur as Medical Director

| June 9, 2017 | 0 Comments

VisionGate, Inc. recently announced the appointment of Dr. David Wilbur as Medical Director of its Phoenix-based CLIA laboratory, VisionGate Biosignatures Laboratory (VBL). A world-renowned pathologist, Dr. Wilbur comes to VisionGate from Massachusetts General Hospital (MGH), where he has been a practicing pathologist since 2001. He headed the Cytopathology Unit until 2011, when he took over the […]

Continue Reading

FDA Approval of Immunotherapy For MSI-High or Mismatch Repair Deficient Tumors

| June 5, 2017 | 0 Comments

Last month the FDA approved pembrolizumab (KEYTRUDA) for adult and pediatric patients with with metastatic or unresectable, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors that have progressed following prior treatment. KEYTRUDA has also been approved fro MSI-H or dMMR colorectal cancers that have progressed following treatment with conventional chemotherapies. The immunooncology/immunotherapy story is fascinating. […]

Continue Reading

Inspirata to Participate in Thought Leadership for Cancer Information Sharing at the Association for Pathology Informatics Annual Summit in Pittsburgh May 22-25

| May 22, 2017 | 0 Comments

Inspirata will showcase its Cancer Diagnostic Cockpit and Consultation Portal as well as present scientific findings on a system that mines relevant information in cancer case reports. Pittsburgh, PA, May 22, 2017 – Cancer diagnostics and pathology workflow solution provider Inspirata®, Inc. announced today that it is exhibiting in booth B2 at the Association for […]

Continue Reading

What does FDA Approval Mean for the Digital Pathology Market? Part 1

| May 15, 2017 | 0 Comments

Much is being said, written and discussed about the recent FDA clearance for Philips digital pathology solution for primary H&E diagnosis. Of course, this means an advantage for Philips right now in the market as the only FDA approved whole slide imaging system for primary diagnosis. For groups and hospitals that appreciate the two main […]

Continue Reading

ASI’s HiPath™ For Computer-Assisted PD-L1 Interpretation

| May 12, 2017 | 0 Comments

HiPath™ Supports Pathologists with Advanced Image Analysis of PD-L1 Assays CARLSBAD, CA, May 11, 2017 — Applied Spectral Imaging (ASI), a global leader of computer-assisted microscopy, introduces HiPath imaging and analysis of PD-L1 assays. PD-L1 is seen as the current breakthrough therapeutic target in immuno-oncology. Following recent clinical advances, PD-L1 expression has become a key factor in […]

Continue Reading

Visiopharm Engages in Major Initiative for Deep Learning in Tissue Based Pathology

Hørsholm, Denmark, May 3rd – Visiopharm A/S announces the first result of their multifaceted strategy to apply Deep Learning technologies to its leading image analysis solution for cancer research and diagnostics. Visiopharm considers Deep Learning an important technological breakthrough for tissue pathology that offers the potential to make a real difference in the assessment of […]

Continue Reading

HALO® Deep Learning Technology Awarded for Automated Breast Cancer Metastasis Staging

Indica Labs proudly announces its breakthrough HALO® Deep Learning technology excelled in the CameLyon17 diagnostic image analysis competition.  The international challenge engaged commercial and academic teams worldwide to develop deep-learning algorithms to analyze 500 whole-slide H&E lymph node images and calculate TNM staging of 100 breast cancer patients. The HALO Deep Learning solution was the […]

Continue Reading

Proscia Takes on Subjectivity in Pathology Through AI Innovation

| April 27, 2017 | 0 Comments

Proscia continues to demonstrate the potential for its technology demonstrating agreement between its algorithms and pathologist reads in detection and classification of breast cancer. Proscia Inc., a data and analytics solutions provider for digital pathology, today announced their digital pathology technology has the potential to eliminate subjectivity in the detection and classification of breast cancer. Using […]

Continue Reading

The Motley Fool: Google AI Just Beat Human Pathologists at Detecting Cancer

| April 5, 2017 | 0 Comments

Apparently it is official…pathologists have been replaced by Google. Just like those folding maps, the yellow pages, the white pages, newspapers, racing forms, microfiche, books and other annoying analog nuances of daily life. The original story is of course not “just”, unless “just” means news going back a month as shown on CNN: Google uses AI to help diagnose breast cancer. […]

Continue Reading

Philips and PathAI Team Up to Improve Breast Cancer Diagnosis Using Artificial Intelligence Technology in ‘Big Data’ Pathology Research

| March 29, 2017 | 0 Comments

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and PathAI, a company that develops artificial intelligence technology for pathology, are collaborating with the aim to develop solutions that improve the precision and accuracy of routine diagnosis of cancer and other diseases. The partnership aims to build deep learning applications in computational pathology, […]

Continue Reading

“Academic” Tweeting – Is it “Academic” and Will it Be Recognized as Such?

| March 23, 2017 | 2 Comments

Dr. Bruce Friedman over at Lab Soft News has an interesting post today on “The “Why” and “How” of Academic Tweeting”. Many of you know that Bruce is widely considered the grandfather of pathology informatics, coining the term decades ago, envisioning organizations, societies, fellowships before many. He and Mike Becich are two people I would […]

Continue Reading